The BRAF activated non‐coding RNA: A pivotal long non‐coding RNA in human malignancies

Long non‐coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non‐coding RNA (BANCR), a 4‐exon transcript of 693‐bp, was first discovered as an oncogenic long non‐coding RNA in BRAFV600E melanomas cells in 201...

Full description

Saved in:
Bibliographic Details
Published inCell proliferation Vol. 51; no. 4; pp. e12449 - n/a
Main Authors Liu, Xiu‐Fen, Hao, Ji‐Long, Xie, Tian, Pant, Om Prakash, Lu, Cheng‐Bo, Lu, Cheng‐Wei, Zhou, Dan‐Dan
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.08.2018
John Wiley and Sons Inc
Subjects
Animals
BANCR
Biomarkers
Biomarkers, Tumor - genetics
Cadherins - metabolism
Cancer
Cell adhesion & migration
Cell migration
Gastric cancer
Humans
long noncoding RNAs (lncRNAs)
Lung cancer
Melanoma
Melanoma - genetics
Melanoma - metabolism
Melanoma - pathology
Mitogen-Activated Protein Kinases - metabolism
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Retina
Retinoblastoma
Review
Ribonucleic acid
RNA
RNA Interference
RNA, Long Noncoding - antagonists & inhibitors
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
Signal Transduction
Transcription
Tumorigenesis
Tumors
tumour accelerator
tumour suppressor
long noncoding RNAs (lncRNAs)
tumour accelerator
tumour suppressor
BANCR
Online AccessGet full text
ISSN0960-7722
1365-2184
1365-2184
DOI10.1111/cpr.12449

Cover

Abstract Long non‐coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non‐coding RNA (BANCR), a 4‐exon transcript of 693‐bp, was first discovered as an oncogenic long non‐coding RNA in BRAFV600E melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR‐targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.
AbstractList Long non‐coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non‐coding RNA (BANCR), a 4‐exon transcript of 693‐bp, was first discovered as an oncogenic long non‐coding RNA in BRAFV600E melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR‐targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.
Long non‐coding RNA s (lnc RNA s) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non‐coding RNA ( BANCR ), a 4‐exon transcript of 693‐bp, was first discovered as an oncogenic long non‐coding RNA in BRAF V 600E melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR ‐targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.
Long non-coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non-coding RNA (BANCR), a 4-exon transcript of 693-bp, was first discovered as an oncogenic long non-coding RNA in BRAF melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR-targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.
Long non‐coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non‐coding RNA (BANCR), a 4‐exon transcript of 693‐bp, was first discovered as an oncogenic long non‐coding RNA in BRAFV600E melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR‐targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.
Long non-coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non-coding RNA (BANCR), a 4-exon transcript of 693-bp, was first discovered as an oncogenic long non-coding RNA in BRAFV600E melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR-targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.Long non-coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non-coding RNA (BANCR), a 4-exon transcript of 693-bp, was first discovered as an oncogenic long non-coding RNA in BRAFV600E melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR-targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.
Author Lu, Cheng‐Bo
Zhou, Dan‐Dan
Lu, Cheng‐Wei
Pant, Om Prakash
Xie, Tian
Hao, Ji‐Long
Liu, Xiu‐Fen
AuthorAffiliation 2 Department of . Neurosurgery The People's Hospital of Jilin Province Jilin China
4 Department of Radiology The First Hospital of Jilin University Jilin China
3 Department of Cardiology The First Hospital of Jiamusi University Heilongjiang China
1 Department of Ophthalmology The First Hospital of Jilin University Jilin China
AuthorAffiliation_xml – name: 1 Department of Ophthalmology The First Hospital of Jilin University Jilin China
– name: 3 Department of Cardiology The First Hospital of Jiamusi University Heilongjiang China
– name: 2 Department of . Neurosurgery The People's Hospital of Jilin Province Jilin China
– name: 4 Department of Radiology The First Hospital of Jilin University Jilin China
Author_xml – sequence: 1
  givenname: Xiu‐Fen
  surname: Liu
  fullname: Liu, Xiu‐Fen
  organization: The First Hospital of Jilin University
– sequence: 2
  givenname: Ji‐Long
  surname: Hao
  fullname: Hao, Ji‐Long
  organization: The First Hospital of Jilin University
– sequence: 3
  givenname: Tian
  surname: Xie
  fullname: Xie, Tian
  organization: The People's Hospital of Jilin Province
– sequence: 4
  givenname: Om Prakash
  surname: Pant
  fullname: Pant, Om Prakash
  organization: The First Hospital of Jilin University
– sequence: 5
  givenname: Cheng‐Bo
  surname: Lu
  fullname: Lu, Cheng‐Bo
  organization: The First Hospital of Jiamusi University
– sequence: 6
  givenname: Cheng‐Wei
  orcidid: 0000-0002-8370-7276
  surname: Lu
  fullname: Lu, Cheng‐Wei
  email: lcwchina800@sina.com
  organization: The First Hospital of Jilin University
– sequence: 7
  givenname: Dan‐Dan
  surname: Zhou
  fullname: Zhou, Dan‐Dan
  email: zhoudan0928@sohu.com
  organization: The First Hospital of Jilin University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29484737$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1uEzEUhS1URNPCghdAltiUxbT-m7GHBVIatQWpAhSVDRvLf0lceewwngnqro_AM_IkdUmpIBJ4cyXf7x6de88B2IspOgBeYnSMyzsx6_4YE8baJ2CCaVNXBAu2ByaobVDFOSH74CDna4Qwxbx5BvZJywTjlE_A16uVg6fz6TlUZvAbNTgLi_rP2x8mWR-XcP5x-hZO4dpv0qACDKn87QLQR7gaOxVhp4JfRhWNd_k5eLpQIbsXD_UQfDk_u5q9ry4_XXyYTS8rwxhtK2q1EIhy3dDaLRy3RlNmCWq14q5GdlFMU9LotlYaCY6sxpYIp2vScMEVpofg3VZ3PerOWePi0Ksg173vVH8jk_Ly7070K7lMG9nURAgmisDRg0Cfvo0uD7Lz2bgQVHRpzJIgJESLBCEFfb2DXqexj2W9QvEGYc4FLdSrPx09Wvl99gK82QKmTzn3bvGIYCTvI5UlUvkr0sKe7LDGD2rw6X4ZH_438d0Hd_NvaTn7PN9O3AGkrLKg
CitedBy_id crossref_primary_10_2174_1389557521666211101161548
crossref_primary_10_1016_j_jbc_2025_108247
crossref_primary_10_18632_aging_102483
crossref_primary_10_1016_j_heliyon_2024_e27629
crossref_primary_10_1155_2022_9083822
crossref_primary_10_1016_j_ejso_2020_05_027
crossref_primary_10_3389_fonc_2023_1107631
crossref_primary_10_1155_2022_1816217
crossref_primary_10_3390_biomedicines12081851
crossref_primary_10_12677_WJCR_2023_132013
crossref_primary_10_2174_1389201023666220624094950
crossref_primary_10_3892_ijo_2019_4848
crossref_primary_10_1186_s12894_018_0395_7
crossref_primary_10_1007_s12253_019_00722_0
crossref_primary_10_1111_jop_13463
crossref_primary_10_1111_jop_12968
crossref_primary_10_18632_aging_202800
crossref_primary_10_3892_mmr_2022_12636
crossref_primary_10_3389_fonc_2024_1346413
Cites_doi 10.1200/JCO.2005.00.554
10.18632/oncotarget.14061
10.4292/wjgpt.v5.i1.40
10.1167/iovs.04-1462
10.1038/onc.2011.621
10.3892/ol.2014.2154
10.1111/dote.12097
10.1007/s12032-013-0464-4
10.1186/s12957-015-0757-5
10.1158/0008-5472.CAN-10-2483
10.4238/gmr.15017480
10.3322/caac.21262
10.1016/j.biopha.2014.11.027
10.1200/JCO.2003.08.132
10.1016/j.bbrc.2015.07.158
10.1097/ICU.0b013e328338676a
10.3892/ijo.2017.4173
10.1016/j.bpg.2015.09.018
10.1097/ICU.0000000000000002
10.21873/cgp.20027
10.1016/S0140-6736(16)31012-1
10.1111/j.1751-1097.2007.00283.x
10.3322/caac.20138
10.1016/j.biopha.2015.04.007
10.1016/j.ejca.2015.10.009
10.1016/j.ypmed.2014.02.010
10.1002/ijc.25516
10.1038/nrc2694
10.1016/j.biopha.2015.02.021
10.1159/000452577
10.1038/sj.bjc.6605399
10.1371/journal.pone.0100893
10.1186/1476-4598-13-68
10.1097/MD.0000000000004436
10.1371/journal.pone.0122679
10.1007/s13277-015-3413-3
10.1101/gr.140061.112
10.3892/ol.2014.2487
10.7150/thno.16044
10.4143/crt.2015.118
10.1186/s40659-017-0136-5
10.1186/s13046-016-0397-9
10.3322/caac.20107
10.4254/wjh.v7.i12.1632
10.3892/ol.2017.6770
10.18632/oncotarget.10825
10.1016/j.bbrc.2015.08.068
10.1016/j.biopha.2016.05.014
10.1016/j.ccr.2006.06.016
10.1007/s00432-016-2238-9
10.1016/j.tcb.2011.04.001
ContentType Journal Article
Copyright 2018 John Wiley & Sons Ltd
2018 John Wiley & Sons Ltd.
Copyright © 2018 John Wiley & Sons Ltd
Copyright_xml – notice: 2018 John Wiley & Sons Ltd
– notice: 2018 John Wiley & Sons Ltd.
– notice: Copyright © 2018 John Wiley & Sons Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
P64
7X8
5PM
DOI 10.1111/cpr.12449
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Engineering Research Database

MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate LIU et al
EISSN 1365-2184
EndPage n/a
ExternalDocumentID PMC6528848
29484737
10_1111_cpr_12449
CPR12449
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: The First Hospital of Jilin University Grant
  funderid: JDYY72016055
– fundername: The First Hospital of Jilin University Grant
  grantid: JDYY72016055
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29B
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANHP
AAONW
AAZKR
ABCQN
ABDBF
ABEML
ABPVW
ACBWZ
ACCFJ
ACCMX
ACGFS
ACIWK
ACMXC
ACPRK
ACRPL
ACSCC
ACUHS
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADNMO
ADPDF
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AEUYN
AFBPY
AFEBI
AFKRA
AFPWT
AFRAH
AFZJQ
AHEFC
AI.
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
ATUGU
AVUZU
AZBYB
AZFZN
AZVAB
BAFTC
BBNVY
BCNDV
BDRZF
BENPR
BFHJK
BHBCM
BHPHI
BMXJE
BROTX
BRXPI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GLUZI
GODZA
GROUPED_DOAJ
H.X
HCIFZ
HF~
HVGLF
HZI
HZ~
IAO
IGS
IHE
IHR
INH
ITC
IX1
J0M
K48
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
M7P
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
OVEED
P2W
P2X
P2Z
P4B
P4D
PALCI
PIMPY
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RPM
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
VH1
W8V
W99
WBKPD
WH7
WIB
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WOW
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
XG1
ZXP
~IA
~WT
AAYXX
ABJNI
AGQPQ
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
P64
7X8
5PM
ID FETCH-LOGICAL-c4439-3db88037b635efe7dcb34d209ba7e50df131326b95ab0870db1d28eb526787a13
IEDL.DBID DR2
ISSN 0960-7722
1365-2184
IngestDate Thu Aug 21 18:31:38 EDT 2025
Thu Sep 04 17:18:47 EDT 2025
Wed Aug 13 07:57:27 EDT 2025
Thu Apr 03 07:02:21 EDT 2025
Thu Apr 24 22:58:43 EDT 2025
Tue Jul 01 04:15:54 EDT 2025
Wed Jan 22 16:49:05 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords long noncoding RNAs (lncRNAs)
tumour accelerator
tumour suppressor
BANCR
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2018 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4439-3db88037b635efe7dcb34d209ba7e50df131326b95ab0870db1d28eb526787a13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Xiu‐Fen Liu and Ji‐Long Hao have contributed equally to this work.
ORCID 0000-0002-8370-7276
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cpr.12449
PMID 29484737
PQID 2076017783
PQPubID 2045182
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6528848
proquest_miscellaneous_2008890822
proquest_journals_2076017783
pubmed_primary_29484737
crossref_primary_10_1111_cpr_12449
crossref_citationtrail_10_1111_cpr_12449
wiley_primary_10_1111_cpr_12449_CPR12449
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2018
PublicationDateYYYYMMDD 2018-08-01
PublicationDate_xml – month: 08
  year: 2018
  text: August 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
– name: Hoboken
PublicationTitle Cell proliferation
PublicationTitleAlternate Cell Prolif
PublicationYear 2018
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2017; 7
2015; 36
2017; 8
2006; 73
2015; 71
2013; 24
2015; 465
2015; 72
2011; 61
2016; 388
2014; 62
2016; 142
2005; 23
2016; 35
2010; 21
2014; 5
2011; 71
2011; 21
2016; 40
2014; 13
2016; 82
2014; 9
2014; 8
2012; 22
2016; 48
2010; 8
2012; 62
2015; 19
2010; 127
2006; 10
2015; 10
2016; 53
2016; 95
2016; 15
2015; 7
2016; 14
2012; 31
2005; 46
2017; 51
2017; 50
2015; 69
2015; 28
2015; 29
2017; 14
2015; 65
2013; 30
2009; 101
2009; 9
2008; 84
2003; 21
e_1_2_10_23_1
e_1_2_10_46_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
e_1_2_10_40_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_53_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_55_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
e_1_2_10_51_1
Geller DS (e_1_2_10_18_1) 2010; 8
Fan YH (e_1_2_10_27_1) 2015; 19
e_1_2_10_29_1
e_1_2_10_25_1
e_1_2_10_48_1
e_1_2_10_24_1
e_1_2_10_45_1
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_20_1
e_1_2_10_41_1
Melamud A (e_1_2_10_13_1) 2006; 73
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_54_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_31_1
e_1_2_10_50_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_26_1
e_1_2_10_47_1
References_xml – volume: 48
  start-page: 698
  year: 2016
  end-page: 707
  article-title: BRAF‐activated long noncoding RNA modulates papillary thyroid carcinoma cell proliferation through regulating thyroid stimulating hormone receptor
  publication-title: Cancer Res Treat
– volume: 8
  start-page: 238
  year: 2017
  end-page: 247
  article-title: BRAF‐activated LncRNA functions as a tumor suppressor in papillary thyroid cancer
  publication-title: Oncotarget
– volume: 7
  start-page: 1632
  year: 2015
  end-page: 1651
  article-title: Guide for diagnosis and treatment of hepatocellular carcinoma
  publication-title: World J Hepatol
– volume: 71
  start-page: 3
  year: 2011
  end-page: 7
  article-title: Long intergenic noncoding RNAs: new links in cancer progression
  publication-title: Can Res
– volume: 50
  start-page: 32
  year: 2017
  article-title: Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
  publication-title: Biol Res
– volume: 46
  start-page: 2683
  year: 2005
  end-page: 2691
  article-title: Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture
  publication-title: Invest Ophthalmol Vis Sci
– volume: 8
  start-page: 705
  year: 2010
  end-page: 718
  article-title: Osteosarcoma: a review of diagnosis, management, and treatment strategies
  publication-title: Clin Adv Hematol Oncol
– volume: 8
  start-page: 1947
  year: 2014
  end-page: 1952
  article-title: BRAF‐activated long non‐coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma
  publication-title: Oncol Lett
– volume: 71
  start-page: 79
  year: 2015
  end-page: 83
  article-title: Up‐regulation of BRAF activated non‐coding RNA is associated with radiation therapy for lung cancer
  publication-title: Biomed Pharmacother
– volume: 21
  start-page: 2011
  year: 2003
  end-page: 2018
  article-title: Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
  publication-title: J Clin Oncol
– volume: 9
  start-page: e100893
  year: 2014
  article-title: Long non‐coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation
  publication-title: PLoS ONE
– volume: 29
  start-page: 885
  year: 2015
  end-page: 893
  article-title: Early esophageal cancer screening in China
  publication-title: Best Pract Res Clin Gastroenterol
– volume: 61
  start-page: 69
  year: 2011
  end-page: 90
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
– volume: 10
  start-page: 99
  year: 2006
  end-page: 111
  article-title: Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
  publication-title: Cancer Cell
– volume: 9
  start-page: 537
  year: 2009
  end-page: 549
  article-title: Signal integration by JNK and p38 MAPK pathways in cancer development
  publication-title: Nature Rev Cancer.
– volume: 22
  start-page: 1006
  year: 2012
  end-page: 1014
  article-title: BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration
  publication-title: Genome Res
– volume: 40
  start-page: 644
  year: 2016
  end-page: 656
  article-title: Long non‐coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathway
  publication-title: Cell Physiol Biochem
– volume: 84
  start-page: 528
  year: 2008
  end-page: 536
  article-title: Role of UV in cutaneous melanoma
  publication-title: Photochem Photobiol
– volume: 36
  start-page: 7205
  year: 2015
  end-page: 7211
  article-title: Long non‐coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma
  publication-title: Tumour Biol
– volume: 127
  start-page: 2893
  year: 2010
  end-page: 2917
  article-title: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
  publication-title: Int J Cancer
– volume: 8
  start-page: 6295
  year: 2017
  end-page: 6303
  article-title: BRAF‐activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta‐analysis
  publication-title: Oncotarget
– volume: 14
  start-page: 8
  year: 2016
  article-title: Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma
  publication-title: World J Surg Oncol
– volume: 51
  start-page: 1941
  year: 2017
  end-page: 1951
  article-title: BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR204
  publication-title: Int J Oncol
– volume: 31
  start-page: 4577
  year: 2012
  end-page: 4587
  article-title: Long non‐coding RNAs and cancer: a new frontier of translational research?
  publication-title: Oncogene
– volume: 5
  start-page: 40
  year: 2014
  end-page: 49
  article-title: Aspirin, cyclooxygenase inhibition and colorectal cancer
  publication-title: World J Gastrointest Pharmacol Ther
– volume: 82
  start-page: 406
  year: 2016
  end-page: 412
  article-title: Upregulation of the long non‐coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma
  publication-title: Biomed Pharmacother
– volume: 21
  start-page: 203
  year: 2010
  end-page: 212
  article-title: Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra‐arterial chemotherapy
  publication-title: Curr Opin Ophthalmol
– volume: 72
  start-page: 109
  year: 2015
  end-page: 112
  article-title: Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer
  publication-title: Biomedicine Pharmacother.
– volume: 142
  start-page: 2291
  year: 2016
  end-page: 2301
  article-title: Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer
  publication-title: J Cancer Res Clin Oncol
– volume: 465
  start-page: 225
  year: 2015
  end-page: 231
  article-title: BRAF activated non‐coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF‐kappaB1
  publication-title: Biochem Biophys Res Comm
– volume: 21
  start-page: 354
  year: 2011
  end-page: 361
  article-title: Long noncoding RNAs and human disease
  publication-title: Trends Cell Biol
– volume: 35
  start-page: 125
  year: 2016
  article-title: Over‐expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer
  publication-title: J Exp Clin Cancer Res.
– volume: 73
  start-page: 1039
  year: 2006
  end-page: 1044
  article-title: Retinoblastoma
  publication-title: Am Fam Physician
– volume: 95
  start-page: e4436
  year: 2016
  article-title: The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis
  publication-title: Medicine
– volume: 10
  start-page: e0122679
  year: 2015
  article-title: Downregulated long noncoding RNA BANCR promotes the proliferation of colorectal cancer cells via downregualtion of p21 expression
  publication-title: PLoS ONE
– volume: 65
  start-page: 87
  year: 2015
  end-page: 108
  article-title: Global cancer statistics, 2012
  publication-title: CA Cancer J Clin
– volume: 24
  start-page: 581
  year: 2013
  end-page: 588
  article-title: Retinoblastoma
  publication-title: Curr Opin Ophthalmol
– volume: 8
  start-page: 869
  year: 2014
  end-page: 875
  article-title: BRAF‐activated long non‐coding RNA contributes to colorectal cancer migration by inducing epithelial‐mesenchymal transition
  publication-title: Oncol Lett
– volume: 30
  start-page: 464
  year: 2013
  article-title: Metastatic gastric cancer treatment: a little slow but worthy progress
  publication-title: Med Oncol
– volume: 465
  start-page: 594
  year: 2015
  end-page: 600
  article-title: Fentanyl inhibits the invasion and migration of colorectal cancer cells via inhibiting the negative regulation of Ets‐1 on BANCR
  publication-title: Biochem Biophys Res Comm
– volume: 13
  start-page: 68
  year: 2014
  article-title: Downregulation of BRAF activated non‐coding RNA is associated with poor prognosis for non‐small cell lung cancer and promotes metastasis by affecting epithelial‐mesenchymal transition
  publication-title: Mol Cancer
– volume: 23
  start-page: 3742
  year: 2005
  end-page: 3751
  article-title: Childhood cancer survival trends in Europe: a EUROCARE Working Group study
  publication-title: J Clin Oncol
– volume: 28
  start-page: 59
  year: 2015
  end-page: 67
  article-title: Dietary habits and esophageal cancer
  publication-title: Dis Esophagus
– volume: 15
  issue: 1
  year: 2016
  article-title: Increased expression of the lncRNA BANCR and its prognostic significance in human osteosarcoma
  publication-title: Genet Mol Res
– volume: 14
  start-page: 4751
  year: 2017
  end-page: 4757
  article-title: Downregulation of BRAF‐activated non‐coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells
  publication-title: Oncol Lett
– volume: 14
  start-page: 143
  year: 2017
  end-page: 160
  article-title: Long non‐coding RNAs and their role in metastasis
  publication-title: Cancer Genomics Proteomics
– volume: 101
  start-page: S102
  issue: Suppl 2
  year: 2009
  end-page: S109
  article-title: Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?
  publication-title: Br J Cancer
– volume: 388
  start-page: 1459
  year: 2016
  end-page: 1544
  article-title: Causes of Death C. Global, regional, and national life expectancy, all‐cause mortality, and cause‐specific mortality for 249 causes of death, 1980‐2015: a systematic analysis for the Global Burden of Disease Study 2015
  publication-title: Lancet
– volume: 7
  start-page: 213
  year: 2017
  end-page: 227
  article-title: Genome‐wide lncRNA microarray profiling identifies novel circulating lncRNAs for detection of gastric cancer
  publication-title: Theranostics
– volume: 62
  start-page: 10
  year: 2012
  end-page: 29
  article-title: Cancer statistics, 2012
  publication-title: CA Cancer J Clin
– volume: 62
  start-page: 132
  year: 2014
  end-page: 141
  article-title: Colorectal cancer prevention in Europe: burden of disease and status of screening programs
  publication-title: Prev Med
– volume: 69
  start-page: 90
  year: 2015
  end-page: 95
  article-title: Long non‐coding RNA BANCR promotes proliferation and migration of lung carcinoma via MAPK pathways
  publication-title: Biomed Pharmacother
– volume: 53
  start-page: 25
  year: 2016
  end-page: 32
  article-title: MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
  publication-title: Eur J Cancer
– volume: 19
  start-page: 3593
  year: 2015
  end-page: 3604
  article-title: Overexpression of miR‐98 inhibits cell invasion in glioma cell lines via downregulation of IKKepsilon
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 19
  start-page: 3593
  year: 2015
  ident: e_1_2_10_27_1
  article-title: Overexpression of miR‐98 inhibits cell invasion in glioma cell lines via downregulation of IKKepsilon
  publication-title: Eur Rev Med Pharmacol Sci
– ident: e_1_2_10_14_1
  doi: 10.1200/JCO.2005.00.554
– ident: e_1_2_10_31_1
  doi: 10.18632/oncotarget.14061
– ident: e_1_2_10_39_1
  doi: 10.4292/wjgpt.v5.i1.40
– ident: e_1_2_10_11_1
  doi: 10.1167/iovs.04-1462
– ident: e_1_2_10_17_1
  doi: 10.1038/onc.2011.621
– ident: e_1_2_10_43_1
  doi: 10.3892/ol.2014.2154
– ident: e_1_2_10_23_1
  doi: 10.1111/dote.12097
– ident: e_1_2_10_26_1
  doi: 10.1007/s12032-013-0464-4
– ident: e_1_2_10_37_1
  doi: 10.1186/s12957-015-0757-5
– ident: e_1_2_10_16_1
  doi: 10.1158/0008-5472.CAN-10-2483
– ident: e_1_2_10_20_1
  doi: 10.4238/gmr.15017480
– ident: e_1_2_10_22_1
  doi: 10.3322/caac.21262
– ident: e_1_2_10_53_1
  doi: 10.1016/j.biopha.2014.11.027
– ident: e_1_2_10_19_1
  doi: 10.1200/JCO.2003.08.132
– ident: e_1_2_10_29_1
  doi: 10.1016/j.bbrc.2015.07.158
– ident: e_1_2_10_12_1
  doi: 10.1097/ICU.0b013e328338676a
– ident: e_1_2_10_8_1
  doi: 10.3892/ijo.2017.4173
– ident: e_1_2_10_24_1
  doi: 10.1016/j.bpg.2015.09.018
– ident: e_1_2_10_10_1
  doi: 10.1097/ICU.0000000000000002
– ident: e_1_2_10_3_1
  doi: 10.21873/cgp.20027
– ident: e_1_2_10_2_1
  doi: 10.1016/S0140-6736(16)31012-1
– ident: e_1_2_10_6_1
  doi: 10.1111/j.1751-1097.2007.00283.x
– ident: e_1_2_10_50_1
  doi: 10.3322/caac.20138
– ident: e_1_2_10_32_1
  doi: 10.1016/j.biopha.2015.04.007
– ident: e_1_2_10_28_1
  doi: 10.1016/j.ejca.2015.10.009
– ident: e_1_2_10_40_1
  doi: 10.1016/j.ypmed.2014.02.010
– ident: e_1_2_10_5_1
  doi: 10.1002/ijc.25516
– ident: e_1_2_10_54_1
  doi: 10.1038/nrc2694
– ident: e_1_2_10_55_1
  doi: 10.1016/j.biopha.2015.02.021
– ident: e_1_2_10_21_1
  doi: 10.1159/000452577
– ident: e_1_2_10_51_1
  doi: 10.1038/sj.bjc.6605399
– ident: e_1_2_10_7_1
  doi: 10.1371/journal.pone.0100893
– ident: e_1_2_10_52_1
  doi: 10.1186/1476-4598-13-68
– ident: e_1_2_10_36_1
  doi: 10.1097/MD.0000000000004436
– ident: e_1_2_10_41_1
  doi: 10.1371/journal.pone.0122679
– ident: e_1_2_10_9_1
  doi: 10.1007/s13277-015-3413-3
– ident: e_1_2_10_4_1
  doi: 10.1101/gr.140061.112
– volume: 73
  start-page: 1039
  year: 2006
  ident: e_1_2_10_13_1
  article-title: Retinoblastoma
  publication-title: Am Fam Physician
– ident: e_1_2_10_46_1
  doi: 10.3892/ol.2014.2487
– ident: e_1_2_10_30_1
  doi: 10.7150/thno.16044
– ident: e_1_2_10_47_1
  doi: 10.4143/crt.2015.118
– ident: e_1_2_10_44_1
  doi: 10.1186/s40659-017-0136-5
– ident: e_1_2_10_49_1
  doi: 10.1186/s13046-016-0397-9
– ident: e_1_2_10_33_1
  doi: 10.3322/caac.20107
– volume: 8
  start-page: 705
  year: 2010
  ident: e_1_2_10_18_1
  article-title: Osteosarcoma: a review of diagnosis, management, and treatment strategies
  publication-title: Clin Adv Hematol Oncol
– ident: e_1_2_10_35_1
  doi: 10.4254/wjh.v7.i12.1632
– ident: e_1_2_10_38_1
  doi: 10.3892/ol.2017.6770
– ident: e_1_2_10_48_1
  doi: 10.18632/oncotarget.10825
– ident: e_1_2_10_45_1
  doi: 10.1016/j.bbrc.2015.08.068
– ident: e_1_2_10_25_1
  doi: 10.1016/j.biopha.2016.05.014
– ident: e_1_2_10_34_1
  doi: 10.1016/j.ccr.2006.06.016
– ident: e_1_2_10_42_1
  doi: 10.1007/s00432-016-2238-9
– ident: e_1_2_10_15_1
  doi: 10.1016/j.tcb.2011.04.001
SSID ssj0013176
Score 2.3176441
SecondaryResourceType review_article
Snippet Long non‐coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated...
Long non‐coding RNA s (lnc RNA s) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated...
Long non-coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e12449
SubjectTerms Animals
BANCR
Biomarkers
Biomarkers, Tumor - genetics
Cadherins - metabolism
Cancer
Cell adhesion & migration
Cell migration
Gastric cancer
Humans
long noncoding RNAs (lncRNAs)
Lung cancer
Melanoma
Melanoma - genetics
Melanoma - metabolism
Melanoma - pathology
Mitogen-Activated Protein Kinases - metabolism
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Retina
Retinoblastoma
Review
Ribonucleic acid
RNA
RNA Interference
RNA, Long Noncoding - antagonists & inhibitors
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
Signal Transduction
Transcription
Tumorigenesis
Tumors
tumour accelerator
tumour suppressor
Title The BRAF activated non‐coding RNA: A pivotal long non‐coding RNA in human malignancies
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcpr.12449
https://www.ncbi.nlm.nih.gov/pubmed/29484737
https://www.proquest.com/docview/2076017783
https://www.proquest.com/docview/2008890822
https://pubmed.ncbi.nlm.nih.gov/PMC6528848
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KQfBF63dqlVV88CXHZTeb3ejTWT2KYJHDQhEhZD-ihzU5encFffJP8G_0L3Fm82GvVRDfQjIh-zGz89vM7G8AnnCvlM0TH2e4d4hTWbrYGCkQyCnBjckqXVFE981hdnCUvj6Wx1vwvD8L0_JDDD_cyDLCek0GXprlOSO3i9MROSc6vJeIjHjzX8747whCEgrLEUInBMk7ViHK4hne3PRFlwDm5TzJ8_g1OKDpdfjQN73NO_k8Wq_MyH67wOr4n33bgWsdMGWTVpNuwJavb8KVtlTl11vwHvWJvZhNpoxOQpwhQnWsbuqf33_Yhtwfmx1OnrEJW8zPGsTz7KTBexcF2LxmoSgg-4Lw_2NbGXh5G46mr97tH8RdXYbYpohfYuEMWr1QBsGKr7xy1ojU8XFuSuXl2FUJ8UFmJpelGeN64EziuPZGcvSMqkzEHdjGBvh7wLSwWSqFzErctuWV0tIllfOiKq3kTvkInvYzVNiOtJxqZ5wU_eYFh6oIQxXB40F00TJ1_Elor5_mojPWZcEpOpkopUUEj4bHaGYUOylr36yXoVqnpvLwPIK7rVYMX-F5ij5eqAjUhr4MAkThvfmknn8KVN6Z5FqnGrsZ1OHvDS_2387Cxe6_i96HqwjvdJuuuAfbq9O1f4AQamUeBlv5BYn5GK4
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkQvlGcJLWAQBy5Zbew4dhCXpbBaoF2hVStVSCiKH4EVJVl1dyvBiZ_Ab-SXMHYedFuQELconih-zHi-8YxnAJ5QK4ROIxsmaDuEMc9NqBRnCOQEo0olhSycR3d_nIwO4zdH_GgNnrd3Yer8EN2Bm5MMv187AXcH0mekXM9Oek47pZfgcoxAw5leLyf0tw8h8qXlHEZ3GJI2eYVcHE_36ao2ugAxL0ZKnkWwXgUNN-FD2_k68uRzb7lQPf3tXF7H_x3ddbjWYFMyqJnpBqzZ8iZcqatVfr0F75GlyIvJYEjcZYhTBKmGlFX58_sPXTkNSCbjwTMyILPpaYWQnhxX-O48AZmWxNcFJF_QAvhYFwee34bD4auD3VHYlGYIdYwQJmRGoeAzoRCv2MIKoxWLDe2nKheW900RuZSQiUp5rvq4JRgVGSqt4hSVo8gjdgfWsQP2LhDJdBJzxpMcLbe0EJKbqDCWFbnm1AgbwNN2iTLd5C135TOOs9Z-wanK_FQF8LgjndXJOv5EtNOuc9bI6zyjzkEZCSFZAI-6ZpQ05z7JS1st575gp3QV4mkAWzVbdH-haYxqnokAxArDdAQui_dqSzn95LN5J5xKGUscpueHv3c823038Q_3_p30IVwdHezvZXuvx2-3YQPRnqyjF3dgfXGytPcRUS3UAy84vwADzxzN
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIhAXoDwDhRrEgUtWGzuOnXLaFlYtj1W1olKFkKL4EVhRklV3txI98RP4jfySjp0H3RYk1FuUTBQ_ZjyfM-P5AF5QK4ROIxsmuHcIY56bUCnOEMgJRpVKClm4iO6HUbKzH7894Acr8Ko9C1PXh-h-uDnL8Ou1M_CpKc4YuZ4e9ZxzSq_A1ThBJOEQ0Zj-CSFEnlnOQXQHIWlTVsil8XSvLjujCwjzYqLkWQDrPdDwFnxu214nnnzrLeaqp0_OlXW8ZOduw80GmZJBrUprsGLLO3Ct5qr8cRc-oUKRrfFgSNxRiGOEqIaUVfn75y9dOf9HxqPBJhmQ6eS4QkBPDiu8d16ATEriWQHJd8T_X2pq4Nk92B---bi9EzbEDKGOEcCEzCg0eyYUohVbWGG0YrGh_VTlwvK-KSJXEDJRKc9VHxcEoyJDpVWcomsUecTuwyo2wD4EIplOYs54kuO-LS2E5CYqjGVFrjk1wgbwsp2hTDdVyx15xmHW7l5wqDI_VAE870SndamOvwmtt9OcNdY6y6gLT0ZCSBbAs-4x2pkLnuSlrRYzT9cpHT88DeBBrRXdV2gao5NnIgCxpC-dgKvhvfyknHz1tbwTTqWMJXbTq8O_G55t7439xaP_F92A63uvh9n73dG7x3ADoZ6sUxfXYXV-tLBPEE7N1VNvNqegxxt8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+BRAF+activated+non%E2%80%90coding+RNA%3A+A+pivotal+long+non%E2%80%90coding+RNA+in+human+malignancies&rft.jtitle=Cell+proliferation&rft.au=Xiu%E2%80%90Fen+Liu&rft.au=Ji%E2%80%90Long+Hao&rft.au=Xie%2C+Tian&rft.au=Pant%2C+Om+Prakash&rft.date=2018-08-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=0960-7722&rft.eissn=1365-2184&rft.volume=51&rft.issue=4&rft_id=info:doi/10.1111%2Fcpr.12449&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-7722&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-7722&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-7722&client=summon